Galectin Therapeutics Inc (GALT)
2.19
+0.13
(+6.31%)
USD |
NASDAQ |
Jul 08, 16:00
2.19
0.00 (0.00%)
After-Hours: 18:53
Galectin Therapeutics SG&A Expense (Annual): 5.942M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.942M |
| December 31, 2022 | 6.615M |
| December 31, 2021 | 6.361M |
| December 31, 2020 | 5.468M |
| December 31, 2019 | 5.971M |
| December 31, 2018 | 7.131M |
| December 31, 2017 | 4.526M |
| December 31, 2016 | 6.156M |
| December 31, 2015 | 6.965M |
| December 31, 2014 | 7.005M |
| December 31, 2013 | 6.416M |
| December 31, 2012 | 5.372M |
| Date | Value |
|---|---|
| December 31, 2011 | 6.857M |
| December 31, 2010 | 3.817M |
| December 31, 2009 | 4.983M |
| December 31, 2008 | 3.552M |
| December 31, 2007 | 4.402M |
| December 31, 2006 | 4.029M |
| December 31, 2005 | 3.615M |
| December 31, 2004 | 4.262M |
| December 31, 2003 | 2.988M |
| December 31, 2002 | 1.804M |
| December 31, 2001 | 1.289M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
5.468M
Minimum
2020
6.615M
Maximum
2022
6.071M
Average
5.971M
Median
2019
SG&A Expense (Annual) Benchmarks
| Intuitive Surgical Inc | 1.964B |
| Palatin Technologies Inc | 15.29M |
| Adial Pharmaceuticals Inc | 5.621M |
| Benitec Biopharma Inc | 6.382M |
| Outset Medical Inc | 141.46M |